- Home
- NRO vs ORMP Comparison
NRO vs ORMP Comparison
Compare NRO & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRO | ORMP |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.3M | 197.6M |
| IPO Year | 2003 | 2010 |
Fundamental Metrics
Financial Performance| Metric | NRO | ORMP |
|---|---|---|
| Price | $2.59 | $4.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 218.4K | 152.9K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 2.76 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.72 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $2.55 | $2.09 |
| 52 Week High | $3.28 | $5.47 |
Technical Indicators
Market Signals| Indicator | NRO | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 21.63 | 47.15 |
| Support Level | N/A | $4.54 |
| Resistance Level | $3.09 | $5.01 |
| Average True Range (ATR) | 0.06 | 0.15 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 12.07 | 36.14 |
Price Performance
Historical ComparisonAbout NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.